MedTrace Logo

Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the US

NCT06051669 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 418

Last updated 2023-10-13

No results posted yet for this study

Summary

This is a multi-center, cross-sectional, and prospective study that will recruit patients from multiple hospitals or outpatient clinics in the USA to the comparison of iLivTouch and FibroScan for the assessment of liver fibrosis and steatosis in adult patients.

Conditions

Interventions

DEVICE

iLivTouch

The examination with iLivTouch will be performed in each subject following the sequence determined by the randomization results.

DEVICE

FibroScan

The examination with FibroScan will be performed in each subject following the sequence determined by the randomization results.

Sponsors & Collaborators

  • NYU Langone Health

    collaborator OTHER

  • Stanford University

    collaborator OTHER

  • Rush University

    collaborator OTHER

  • Baylor University

    collaborator OTHER

  • Wuxi Hisky Medical Technology Co Ltd

    collaborator INDUSTRY

  • New Discovery LLC

    lead INDUSTRY

Principal Investigators

  • Calvin Q. Pan · New York University Langone Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-24
Primary Completion
2024-09-30
Completion
2025-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06051669 on ClinicalTrials.gov